Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
306 Results Found
DEA and HHS delay implementation of buprenorphine final rule
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding telemedicine prescribing of buprenorphine will be delayed from Feb. 18 to March 21.
New infographic shows hospitals’ massive economic and community impact
The AHA released an infographic Feb. 13 highlighting the many ways hospitals and health systems advance health and support their communities.
White House EO establishes Make America Healthy Again Commission
President Trump Feb. 13 signed an executive order establishing the Make America Healthy Again Commission, to be chaired by Department of Health and Human Services Secretary Robert F. Kennedy Jr. The commission is tasked with “investigating and addressing the root causes of America’s escalating health crisis, with an initial focus on childhood chronic diseases.”
Study shows importance of vitamin D levels for infant health
A study by the Penn State Department of Nut
Taking the Lead in Developing the Health Care Leaders of Tomorrow
The AHA Next Generation Leaders Fellowship focuses on developing leaders and empowering them to bring about real and lasting change in the hospitals and health systems in which they serve, as well as our field overall.
CDC: U.S. maternal mortality rate declined in 2023
The U.S. maternal mortality rate decreased to 18.6 deaths per 100,000 live births in 2023, down from 22.3 in 2022, according to new data from the Centers for Disease Control and Prevention.
AHA podcast: Caring for Our Kids — How OHSU Is Addressing Psychosocial Needs in Complex Pediatric Patients
In this new “Caring for Our Kids” episode, David Wagner, pediatric psychologist at Oregon Health and Science University, discusses the Novel Interventions in Children's Healthcare program and how this innovative approach is transforming care for vulnerable children.
FDA approves first-in-class non-opioid painkiller
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.
Chair File: Leadership Dialogue — Addressing the Behavioral Health Crisis with Jesse Tamplen of John Muir Health
On this episode, I talk with Jesse Tamplen, vice president of behavioral health services at John Muir Health, located east of San Francisco, and a member of the AHA Committee on Behavioral Health.